Bio Pharma Dive

MARCH 11, 2025

Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S.

Pharma Companies 357

Pharma Companies Vaccination Vaccine Manufacturing 357

Pharmaceutical Technology

MARCH 11, 2025

AWSs framework will speed up the analysis of ElevateBios large protein datasets, hinting at promising drug candidates.

Protein 179

Protein Drugs 179

Bio Pharma Dive

MARCH 11, 2025

The deal ends 2Seventy’s short run as an independent company, during which it restructured, sold off research and lost nearly all of its market value.

Marketing 284

Marketing Research 284

Pharmaceutical Technology

MARCH 11, 2025

The multi-year manufacturing deal with CordenPharma will secure future supply of VK2735 if it goes to market.

Manufacturing 165

Manufacturing Drugs Marketing 165

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Bio Pharma Dive

MARCH 11, 2025

The biotech will commit $150 million to an alliance that hands it significant production capacity for a closely watched weight loss treatment.

Drugs 162

Drugs Production 162

Pharmaceutical Technology

MARCH 11, 2025

The deal comes after a challenging few years for 2seventy bio, which had divested research programmes in recent years.

Research 162

Research 162

Pharmaceutical Technology

MARCH 11, 2025

Lundbeck has gained ODD from Japans Ministry of Health, Labor and Welfare (MHLW) for amlenetug to treat multiple system atrophy (MSA).

Drugs 162

Drugs 162

XTalks

MARCH 11, 2025

Arvinas and Pfizer have reported positive Phase III VERITAC-2 results in a trial of 624 patients across 26 countries, demonstrating that vepdegestrant (ARV-471) monotherapy significantly improves progression-free survival in adults with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer.

Trials 59

Trials Clinical Trials Clinical Trials Protein 59

Pharmaceutical Technology

MARCH 11, 2025

MSD has opened a $1bn facility in Durham located in the US state of North Carolina, to increase vaccine manufacturing capacity.

Vaccination 147

Vaccination Vaccine Production Manufacturing 147

Bio Pharma Dive

MARCH 11, 2025

Kelly, who made several key hires at the CDRH and helped negotiate the last user fee agreement, announced his departure in a LinkedIn post Sunday.

130

130

Advertisement

Clinical Supply

Pharmaceutical Technology

MARCH 11, 2025

The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe conference.

Clinical Trials 147

Clinical Trials Clinical Trials Trials 147

Pharma Times

MARCH 11, 2025

Oxford Medical Products targets overweight individuals

Production 106

Production 106

Pharmaceutical Technology

MARCH 11, 2025

Kenox and Lactiga US have announced a strategic partnership for progressing new mucosal-targeted sIgA therapies development.

Development 147

Development 147

Pharma Times

MARCH 11, 2025

CervoMed's therapy demonstrates significant improvement in patients

Trials 101

Trials Drugs 101

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

pharmaphorum

MARCH 11, 2025

Bristol Myers Squibb has moved to take full control of the CAR-T therapy it partners with 2seventy bio, agreeing to buy the biotech for around $286m

80

80

Pharmaceutical Commerce

MARCH 11, 2025

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, offers his perspective on the state of CGTs, along with their potential for transforming medicine.

Gene Therapy 59

Gene Therapy Gene Medicine 59

pharmaphorum

MARCH 11, 2025

Pfizer and Arvinas' much-anticipated oral SERD vepdegestrant for breast cancer missed a key endpoint in its first phase 3 readout

Drugs 73

Drugs 73

Pharmaceutical Commerce

MARCH 11, 2025

The latest news for pharma industry insiders.

59

59

Advertisement

Clinical Supply

pharmaphorum

MARCH 11, 2025

Lila Sciences has emerged with $200m in seed financing to advance its vision of AI-powered, fully autonomous labs to power scientific advances

66

66

Rethinking Clinical Trials

MARCH 11, 2025

The study design paper for the MOMs Chat & Care Study has been published online ahead of print in Contemporary Clinical Trials. Congratulations to the study team on reaching this important milestone for all NIH Collaboratory Trials! The MOMs Chat and Care Study is testing the effectiveness of an integrated care model approach at 2 levels of intensity designed to facilitate timely, appropriate care for Black birthing people to reduce their risk for severe maternal morbidity.

Clinical Trials 146

Clinical Trials Clinical Trials Nurses Trials 146

pharmaphorum

MARCH 11, 2025

Changing Faces: Digital features the latest supplier hires in February 2025, including ViCentra, VisionHealth, Sapio Sciences, Syncell, and more. Stay updated on industry trends and developments in the digital sector.

Development 52

Development 52

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 11, 2025

Psilocybin is a key compound in magic mushrooms. (Cannabis-Pic/Getty Images) Scientists are investigating whether the psychedelic ingredient in magic mushrooms can put a brain ‘back together’ after head injuries. Preliminary research on female rats, which is not yet peer-reviewed, has “absolutely stunned” researchers at Northeastern University with its possibilities.

Scientist 130

Scientist Research Clinical Trials Clinical Trials 130

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

pharmaphorum

MARCH 11, 2025

The shake-up of NHS England looks like it could go up a notch, as reports suggest thousands of job cuts that could halve its headcount are planned

51

51

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 11, 2025

The Directorate General of Foreign Trade (DGFT) has notified a new Standard Input Output Norm (SION) for metronidazole gel under the chemical & allied product category. This development comes as part of the ongoing efforts to facilitate ease of doing business and enhance the export competitiveness of India’s pharmaceutical industry.

Production 124

Production Development Clinical Trials Clinical Trials 124

pharmaphorum

MARCH 11, 2025

Genmab is facing increased pressure to deliver on its in-house pipeline after Johnson & Johnson exited a partnership on a Darzalex follow-up.

45

45

Worldwide Clinical Trials

MARCH 11, 2025

With the six foundational Chimeric Antigen T-cell (CAR T) therapies achieving remarkably effective results and continued evolution of the technology, CAR T clinical programs in other indications are a rapidly growing space. As these innovative therapies begin clinical trials in new patient communities, its essential to understand how to successfully adapt lessons and processes from oncology CAR T therapies into these studies.

Trials 100

Trials Clinical Trials Clinical Trials Development 100

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

Drug Channels

MARCH 11, 2025

Next week, Drug Channels Institute (DCI) will release our 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. Its the 16th edition of our popular and comprehensive examination of the entire U.S. drug pricing, reimbursement, and dispensing system. For 2024, DCI estimates that total prescription dispensing revenues at retail, mail, long-term care, and specialty pharmacies reached $683 billion, up 9% from the 2023 figure.

Pharmacy 97

Pharmacy Marketing Drugs 97

Antidote

MARCH 11, 2025

When you visit your doctor or receive a new treatment, you may not always stop to think about how that medication, therapy, or procedure came to be, but that treatment went through a long journey before it made its way to you. So, how exactly are these treatments discovered? The answer is clinical studies. Every treatment starts with research, testing, and learning about what works and what doesnt.

Doctors 81

Doctors Doctor Research 81

XTalks

MARCH 11, 2025

Advances in mRNA quantification are paving the way for improved vaccine analytics a critical component as the industry shifts toward multivalent mRNA vaccines. With these vaccines designed to target multiple pathogens or strains simultaneously, the need for universal assays that can rapidly confirm the identity and quantity of several mRNA constructs in one test has never been more urgent.

Vaccination 64

Vaccination Vaccine Development Manufacturing 64

Pharma Marketing Network

MARCH 11, 2025

Introduction Pharma marketing is constantly evolving, with new digital tools, regulatory updates, and data-driven strategies shaping the industry. Staying ahead requires access to reliable resources that help teams navigate the complexities of compliance, engagement, and campaign effectiveness. However, with so much information available, finding the right resources can feel overwhelming.

Marketing 52

Marketing Compliance Regulation Research 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials